Loading...
Loading...
Contributors:
Dataset URI:
83bh82m9m2Supporting data points for flow cytometry, ICCS, and luminex abstract: Prenatal opioid exposure (POE) is an escalating public health concern, yet its impact on neonatal immune development remains poorly defined. This study examined how POE, with or without maternal hepatitis C (HCV) infection, shapes neonatal immunity using umbilical cord blood. Pregnancies included uncomplicated term controls and deliveries in patients with severe opioid use disorder on medication-assisted treatment, with (POE HCV+) or without (POE HCV−) HCV infection. POE was associated with smaller birth size, higher rates of congenital anomalies, and longer intensive care admissions. Immune profiling showed a pro-inflammatory milieu, reduced neuroprotective factors, expanded memory/effector T and B cells, blunted T cell responses, and markedly reduced NK cell frequency and cytotoxicity, especially in POE HCV+ newborns. Monocytes exhibited inflammatory reprogramming with impaired antiviral and tissue repair pathways and disrupted lymphoid–innate immune cell communication. These findings suggest POE-driven immune disequilibrium may underlie adverse early-life outcomes and highlight monitoring and intervention targets.
Keyword(s):
Neonatal Immunology; Opioid.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)